Regenerative Medicine and Stem Cells Technologies

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Sorena Sattari, the vice president for science and technology affairs pointed out that the local potentials of the East Azerbaijan Province can be flourished on the development path of knowledge-based economy during the administrative council meeting, stating: this province has a potential that can be used in the knowledge-based development path.

A team at the University of Manchester have developed a novel stem cell gene therapy approach to treat children with a devastating genetic disease. The approach is currently being developed for clinical trial in patients with the disease.

The first symposium on “Graft versus host disease (GvHD)” will be held within the framework of the third national festival and international congress of stem cells and regenerative medicine will be held with joint cooperation of Iran and France.

Innovation has always been the mantra when it comes to biotech stocks. And as such, the biotech sector has been the key driver for new medicines and therapies over the last decade or so.

The Lancet medical journal Friday withdrew two papers authored by disgraced Italian surgeon Paolo Macchiarini, found guilty of misconduct regarding an experimental windpipe graft procedure of which most recipients died.

Platelet-rich plasma (PRP) is believed to provide pain relief and help improve joint function in degenerative joint disease, but a new study has shown that it does not act by promoting stem cell proliferation or enhance the cartilage formation capabilities of mesenchymal stem cells (MSCs).

When skeletal defects are unable to heal on their own, bone tissue engineering (BTE), a developing field in orthopedics can combine materials science, tissue engineering and regenerative medicine to facilitate bone repair.

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019).

It is known that in vitro fertilization (IVF) can affect the size of the newborns. Children derived from fresh embryo transfer have smaller birth weight, and surprisingly, children derived from frozen embryo transfer have subtly higher birth weight in average.

A new study finds that one of the toughest characters in the immune system, the macrophage, has a nurturing side, at least when it comes to guarding the developing breast.